222 related articles for article (PubMed ID: 10340423)
1. Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report.
Meythaler JM; Guin-Renfroe S; Hadley MN
Am J Phys Med Rehabil; 1999; 78(3):247-54. PubMed ID: 10340423
[TBL] [Abstract][Full Text] [Related]
2. Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience.
Meythaler JM; Guin-Renfroe S; Grabb P; Hadley MN
Arch Phys Med Rehabil; 1999 Jan; 80(1):13-9. PubMed ID: 9915366
[TBL] [Abstract][Full Text] [Related]
3. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
[TBL] [Abstract][Full Text] [Related]
4. Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury.
Meythaler JM; DeVivo MJ; Hadley M
Arch Phys Med Rehabil; 1996 May; 77(5):461-6. PubMed ID: 8629922
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal baclofen for spastic hypertonia from stroke.
Meythaler JM; Guin-Renfroe S; Brunner RC; Hadley MN
Stroke; 2001 Sep; 32(9):2099-109. PubMed ID: 11546903
[TBL] [Abstract][Full Text] [Related]
6. Prospective assessment of tizanidine for spasticity due to acquired brain injury.
Meythaler JM; Guin-Renfroe S; Johnson A; Brunner RM
Arch Phys Med Rehabil; 2001 Sep; 82(9):1155-63. PubMed ID: 11552184
[TBL] [Abstract][Full Text] [Related]
7. Orally delivered baclofen to control spastic hypertonia in acquired brain injury.
Meythaler JM; Clayton W; Davis LK; Guin-Renfroe S; Brunner RC
J Head Trauma Rehabil; 2004; 19(2):101-8. PubMed ID: 15247821
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury.
Stokic DS; Yablon SA; Hayes A
Arch Phys Med Rehabil; 2005 Sep; 86(9):1801-6. PubMed ID: 16181946
[TBL] [Abstract][Full Text] [Related]
9. Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report.
Meythaler JM; McCary A; Hadley MN
J Neurosurg; 1997 Sep; 87(3):415-9. PubMed ID: 9285608
[TBL] [Abstract][Full Text] [Related]
10. Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study.
Francisco GE; Boake C
Arch Phys Med Rehabil; 2003 Aug; 84(8):1194-9. PubMed ID: 12917859
[TBL] [Abstract][Full Text] [Related]
11. Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.
Armstrong RW; Steinbok P; Cochrane DD; Kube SD; Fife SE; Farrell K
J Neurosurg; 1997 Sep; 87(3):409-14. PubMed ID: 9285607
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal baclofen in subjects with spastic hemiplegia: assessment of the antispastic effect during gait.
Rémy-Néris O; Tiffreau V; Bouilland S; Bussel B
Arch Phys Med Rehabil; 2003 May; 84(5):643-50. PubMed ID: 12736875
[TBL] [Abstract][Full Text] [Related]
13. [Case report of intrathecal baclofen administration in a child with severe spasticity attributable to traumatic brain injury].
Matsuda R; Nishimura F; Hirabayashi H; Motoyama Y; Mishima H; Park YS; Nakase H; Sakaki T
Brain Nerve; 2009 Mar; 61(3):313-5. PubMed ID: 19301603
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe, disabling spasticity with continuous intrathecal baclofen therapy following acquired brain injury: the experience of a tertiary institution in Singapore.
Wang ZM; Law JH; King NK; Rajeswaran DK; Soh S; Rao JP; Ng WH; Chua KS
Singapore Med J; 2016 Jan; 57(1):8-12. PubMed ID: 26831310
[TBL] [Abstract][Full Text] [Related]
15. Indwelling intrathecal catheter with subcutaneous abdominal reservoir: a viable baclofen delivery system in severely cachectic patients.
Waqar M; Ellenbogen JR; Kumar R; Sneade C; Zebian B; Williams D; Pettorini BL
J Neurosurg Pediatr; 2014 Oct; 14(4):409-13. PubMed ID: 25084089
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury.
Francisco GE; Hu MM; Boake C; Ivanhoe CB
Brain Inj; 2005 May; 19(5):359-64. PubMed ID: 16094783
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.
Van Schaeybroeck P; Nuttin B; Lagae L; Schrijvers E; Borghgraef C; Feys P
Neurosurgery; 2000 Mar; 46(3):603-9; discussion 609-12. PubMed ID: 10719857
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy.
van Hilten BJ; van de Beek WJ; Hoff JI; Voormolen JH; Delhaas EM
N Engl J Med; 2000 Aug; 343(9):625-30. PubMed ID: 10965009
[TBL] [Abstract][Full Text] [Related]
19. Clinical Experience With Continuous Intrathecal Baclofen Trials Prior to Pump Implantation.
Phillips MM; Miljkovic N; Ramos-Lamboy M; Moossy JJ; Horton J; Buhari AM; Munin MC
PM R; 2015 Oct; 7(10):1052-1058. PubMed ID: 25828204
[TBL] [Abstract][Full Text] [Related]
20. An introduction to trialing intrathecal baclofen in patients with hemiparetic spasticity: a description of 3 cases.
Harned ME; Salles SS; Grider JS
Pain Physician; 2011; 14(5):483-9. PubMed ID: 21927053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
